Found: 15
Select item for more details and to access through your institution.
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 428, doi. 10.1002/ajh.26088
- By:
- Publication type:
- Article
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 654, doi. 10.1093/jnci/djt026
- By:
- Publication type:
- Article
Metastatic hemangiopericytoma with prolonged survival.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 103, doi. 10.1007/s10549-021-06267-8
- By:
- Publication type:
- Article
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 127, doi. 10.1007/s10549-017-4518-8
- By:
- Publication type:
- Article
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 659, doi. 10.1007/s10549-017-4523-y
- By:
- Publication type:
- Article
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223
- By:
- Publication type:
- Article
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00281-1
- By:
- Publication type:
- Article
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289
- By:
- Publication type:
- Article
Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Cabazitaxel Plus Lapatinib as Therapy for HER2<sup>+</sup> Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 1, p. 177, doi. 10.1002/ijc.30049
- By:
- Publication type:
- Article